Syngene Makes Strong Debut On Indian Bourses

Syngene International has made a strong debut on Indian bourses listing at INR295 ($4.6) and closing higher, even as the overall market declined in the country. Syngene is the research services arm of Biocon.

Syngene International has made a strong debut on Indian bourses listing at INR295 ($4.6) and closing higher, even as the overall market declined in the country. Syngene is the research services arm of Biocon.

The Syngene stock touched a high of INR318.20 on the Bombay Stock Exchange (BSE) on Aug.11, before ending at INR310.40.

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip